Latest news

  • Precision medicine pipeline may improve drug treatment for pancreatic cancer

    A team of scientists and clinicians in Clayton, Melbourne, has optimised a non-invasive technique to screen pancreatic cancer patients for responsiveness to specific drugs, and has commenced a trial with a drug currently used to treat colon cancer in the hope it may be effective in treating up to 10 per cent of pancreatic cancer…  Read more

  • Launch of the Gandel Genomics Centre to enable next generation health care

    The new Gandel Genomics Centre, launched at Hudson Institute of Medical Research today (June 19) by Mr Frank McGuire, Parliamentary Secretary for Medical Research, will play a vital role in transforming the future of Victorian healthcare. The Gandel Genomics Centre will utilise world-leading technology capabilities at the Monash Health Translation Precinct and new scientific expertise…  Read more

  • $130,000 grant to tackle the challenges of female contraceptive drug discovery

    Hudson Institute of Medical Research scientists will investigate whether a menstruating species of desert rodent responds to ‘the pill’ in the same way that women do, in a project that will lay the foundation for accelerating the discovery of new safe and effective female contraceptives. The Bill & Melinda Gates Foundation has awarded an AU$130,000…  Read more

  • New research shows placental stem cells could protect against preterm brain injury

    The placenta is a rich source of life for unborn babies, supplying oxygen and sustaining nutrition to the fetus via the umbilical cord. Now, researchers at Hudson Institute of Medical Research and Monash University have shown that stem-like cells taken from the discarded placenta could give preterm babies the best chance at life by preventing…  Read more

  • Help give children a healthier future

    This is Bella, a gorgeous, happy young girl who, sadly, suffers from a common chronic and life-threatening childhood disease, type 1 diabetes. Children like Bella need your help. Bella was just six years old when her mum, Mary, noticed a huge change in her. She was crying a lot, felt moody, was dizzy and lost…  Read more

  • Professor Lois Salamonsen elected as Australian Academy of Science Fellow

    Women’s reproductive health expert Professor Lois Salamonsen has been elected to the Australian Academy of Science, for her outstanding contributions to science. Prof Salamonsen is one of 21 of Australia’s best scientists to be elected to the Academy in 2017, in a rare and esteemed honour. “I feel enormously honoured and humbled by this selection.…  Read more

  • Developing better techniques to diagnose a potentially curable form of hypertension

    A multidisciplinary team of researchers and clinicians from Hudson Institute and Monash Health has refined a complex procedure, adrenal vein sampling (AVS), used to identify a surgically curable form of hypertension caused by primary aldosteronism (PA). The work was presented by clinician-researcher Dr Jun Yang at the International Aldosterone Meeting as well as ENDO 2017…  Read more

  • Hope for babies starved of oxygen at birth

    Kahli Sargent loved going fast in a car or boat, everyone knew she loved it—which is surprising, because her mother was told by doctors at birth that she would never communicate. Kahli Sargent “Kahli’s laughter was unreal, she might not have been able to talk, but she certainly could communicate with everyone around her. She…  Read more

  • New Hudson Institute Director and CEO announced

    We are pleased to announce that Professor Elizabeth Hartland has accepted a position as the new Director and CEO of Hudson Institute of Medical Research. Professor Hartland obtained her BSc (Hons) majoring in Microbiology and Biochemistry and subsequently her PhD in Microbiology from the University of Melbourne. She has held a Royal Society/NHMRC Howard Florey…  Read more

  • Promising new treatment for incurable premature lung disease

    Hudson Institute researchers have discovered a potential safe an effective treatment for bronchopulmonary dysplasia (BPD), which could save preterm babies from the severe lifelong effects of this incurable premature lung disease. The researchers, led by Associate Professor Marcel Nold and Dr Claudia Nold, together with senior scientist Dr Ina Rudloff at The Ritchie Centre showed that…  Read more